Disease
|
Drug/Important Bio-Agent (IBA)
4 | Tyrosine (L-Tyrosine)FDA Link
10/2012
-
07/2011 |
3 | Phosphotransferases (Kinase)IBA
02/2013
-
01/2012 |
3 | 15- (2- (pyrrolidin- 1- yl)ethoxy)- 7,12,25- trioxa- 19,21,24- triazatetracyclo(18.3.1.1(2,5).1(14,18))hexacosa- 1(24),2,4,9,14(26),15,17,20,22- nonaeneIBA
10/2012
-
03/2012 |
3 | Janus Kinase 2IBA
03/2012
-
07/2011 |
2 | 11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA
04/2012
-
07/2011 |
2 | Histone Deacetylase InhibitorsIBA
07/2011
-
03/2010 |
1 | Phosphatidylinositols (Phosphatidylinositol)IBA
11/2014 |
1 | TOR Serine-Threonine KinasesIBA
11/2014 |
1 | ErbB Receptors (EGF Receptor)IBA
02/2013 |
1 | VS-5584IBA
02/2013 |
1 | Mechanistic Target of Rapamycin Complex 1IBA
02/2013 |
1 | Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
04/2012 |
1 | 14- methyl- 20- oxa- 5,7,14,26- tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8(27),9,11,16,21,23- decaeneIBA
01/2012 |
1 | Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2012 |
1 | Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
07/2011 |
1 | Histones (Histone)IBA
03/2010 |
1 | Fluorouracil (Carac)FDA LinkGeneric
03/2010 |
1 | Proteins (Proteins, Gene)FDA Link
12/2008 |
1 | Sirtuin 1IBA
12/2006 |
1 | Insulin (Novolin)FDA Link
12/2006 |
1 | LipidsIBA
12/2006 |
1 | CytokinesIBA
12/2006 |
|
Therapy/Procedure
|